H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Genetics and Molecular Biology D-index 65 Citations 12,408 285 World Ranking 1845 National Ranking 944
Medicine D-index 86 Citations 28,697 448 World Ranking 7215 National Ranking 3960

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Hans-Peter Kiem mainly investigates Transplantation, Immunology, Stem cell, Haematopoiesis and Genetic enhancement. His Transplantation research incorporates elements of Total body irradiation and Immunosuppression. His biological study spans a wide range of topics, including Cytotoxic T cell, Cancer research and Cellular differentiation.

His study in Stem cell is interdisciplinary in nature, drawing from both Immune system and Virology. The various areas that Hans-Peter Kiem examines in his Haematopoiesis study include Progenitor cell, CD34, Bone marrow and Baboon. The concepts of his Genetic enhancement study are interwoven with issues in Leukemia, Pharmacology, In vivo and Cell biology.

His most cited work include:

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects (1252 citations)
  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects (1252 citations)
  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects (1252 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Genetic enhancement, Stem cell, Haematopoiesis, Immunology and Transplantation. His Genetic enhancement research is multidisciplinary, incorporating perspectives in Virology, Viral vector, Hematopoietic stem cell and Severe combined immunodeficiency, In vivo. His work in Stem cell covers topics such as Cancer research which are related to areas like Chemotherapy and Immunotherapy.

His Haematopoiesis study integrates concerns from other disciplines, such as Progenitor cell, CD34, Molecular biology, Transduction and Bone marrow. His Transplantation research incorporates themes from Total body irradiation and Immunosuppression. His Internal medicine research integrates issues from Gastroenterology, Surgery and Oncology.

He most often published in these fields:

  • Genetic enhancement (62.92%)
  • Stem cell (61.65%)
  • Haematopoiesis (61.81%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (32.65%)
  • Progenitor cell (26.31%)
  • Haematopoiesis (61.81%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Progenitor cell, Haematopoiesis, Transplantation and Genetic enhancement. His work carried out in the field of Cancer research brings together such families of science as Leukemia, CD33, In vivo and Immunotherapy. Hans-Peter Kiem has included themes like CD34, Hematopoietic stem cell, Ex vivo and Immunology in his Progenitor cell study.

His study on Haematopoiesis is covered under Stem cell. His studies deal with areas such as T cell, Total body irradiation and CD90 as well as Transplantation. His Genetic enhancement research includes themes of Computational biology, Viral vector, Bioinformatics and Virology.

Between 2018 and 2021, his most popular works were:

  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. (901 citations)
  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. (901 citations)
  • Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy. (101 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

The scientist’s investigation covers issues in Haematopoiesis, Cancer research, Fludarabine, Internal medicine and Stem cell. As part of one scientific family, Hans-Peter Kiem deals mainly with the area of Haematopoiesis, narrowing it down to issues related to the Progenitor cell, and often Ex vivo, Transduction and Antibody. His Fludarabine study combines topics in areas such as Oncology and Immunotherapy.

He combines subjects such as Fetal hemoglobin, Hereditary persistence of fetal hemoglobin, Transfection, Humanized mouse and Transplantation with his study of Stem cell. Hans-Peter Kiem has researched Transplantation in several fields, including Molecular biology, HBG1 and Bone marrow. As a part of the same scientific family, he mostly works in the field of CD90, focusing on Hematopoietic stem cell transplantation and, on occasion, Bioinformatics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier.
Blood (2001)

1553 Citations

Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts

James J.H. Chong;Xiulan Yang;Creighton W. Don;Elina Minami.
Nature (2014)

1088 Citations

Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation

Rainer Storb;Cong Yu;John L. Wagner;H. Joachim Deeg.
Blood (1997)

914 Citations

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

Ingo G H Schmidt-Wolf;Robert S. Negrin;Hans Peter Kiem;Karl G. Blume.
Journal of Experimental Medicine (1991)

859 Citations

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee.
Blood (2011)

543 Citations

Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal

Iman Fares;Jalila Chagraoui;Yves Gareau;Stéphane Gingras.
Science (2014)

400 Citations

Improved Gene Transfer Into Baboon Marrow Repopulating Cells Using Recombinant Human Fibronectin Fragment CH-296 in Combination With Interleukin-6, Stem Cell Factor, FLT-3 Ligand, and Megakaryocyte Growth and Development Factor

Hans Peter Kiem;Hans Peter Kiem;Robert G. Andrews;Robert G. Andrews;Julia Morris;Julia Morris;Laura Peterson;Laura Peterson.
Blood (1998)

375 Citations

Survival of the fittest: in vivo selection and stem cell gene therapy.

Tobias Neff;Brian C. Beard;Hans Peter Kiem.
Blood (2006)

365 Citations

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.

Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano.
Cell (2020)

336 Citations

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Joachim Deeg;Barry Storer;John T. Slattery;Claudio Anasetti.
Blood (2002)

335 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hans Peter Kiem

Rainer Storb

Rainer Storb

Fred Hutchinson Cancer Research Center

Publications: 315

Brenda M. Sandmaier

Brenda M. Sandmaier

Fred Hutchinson Cancer Research Center

Publications: 236

Barry E. Storer

Barry E. Storer

Fred Hutchinson Cancer Research Center

Publications: 166

H. Joachim Deeg

H. Joachim Deeg

Fred Hutchinson Cancer Research Center

Publications: 138

David G. Maloney

David G. Maloney

Fred Hutchinson Cancer Research Center

Publications: 131

Paul J. Martin

Paul J. Martin

Fred Hutchinson Cancer Research Center

Publications: 108

Mary E.D. Flowers

Mary E.D. Flowers

Fred Hutchinson Cancer Research Center

Publications: 84

Stephanie J. Lee

Stephanie J. Lee

Fred Hutchinson Cancer Research Center

Publications: 84

Cynthia E. Dunbar

Cynthia E. Dunbar

National Institutes of Health

Publications: 81

Thomas R. Chauncey

Thomas R. Chauncey

University of Washington

Publications: 78

Ted Gooley

Ted Gooley

Fred Hutchinson Cancer Research Center

Publications: 68

Corey Cutler

Corey Cutler

Harvard University

Publications: 68

Dietger Niederwieser

Dietger Niederwieser

Leipzig University

Publications: 68

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 65

Frederick R. Appelbaum

Frederick R. Appelbaum

Fred Hutchinson Cancer Research Center

Publications: 65

Christopher Baum

Christopher Baum

Hannover Medical School

Publications: 65

Something went wrong. Please try again later.